Literature DB >> 8973207

Casein kinase I alpha and alpha L: alternative splicing-generated kinases exhibit different catalytic properties.

J Zhang1, S D Gross, M D Schroeder, R A Anderson.   

Abstract

Casein kinase I (CKI) is a family of serine/threonine protein kinases found in all eukaryotes examined to date. Here, the rat CKI isoforms alpha and alpha L were cloned and expressed in both eukaryotic and prokaryotic systems. Characterization of the genomic DNA flanking the exon unique to CKI alpha L demonstrated that CKI alpha and CKI alpha L arise by the alternative splicing of a common pre-mRNA molecule. To the best of our knowledge, the alpha L isoform is the only known active serine/threonine kinase to contain an insert within its catalytic domain. Tissue distribution of each splicing isoform was examined by RT-PCR, immunoprecipitation, and Western blotting. Both isoforms were expressed in all tissues tested but at different levels. Bacterially expressed CKI alpha isoforms were active and therefore biochemically characterized. CKI alpha and CKI alpha L proteins were demonstrated to have casein kinase I catalytic properties. More importantly, the recombinant isoform proteins exhibited differences in binding and activity toward common CKI substrates. These observations demonstrate that the alpha L insert within the kinase domain modulates substrate kinetics. These kinetic differences suggest that CKI alpha and CKI alpha L may perform different biological roles.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8973207     DOI: 10.1021/bi9614444

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  12 in total

1.  Evolutionary conservation of alternative splicing in chicken.

Authors:  S Katyal; Z Gao; R-Z Liu; R Godbout
Journal:  Cytogenet Genome Res       Date:  2007       Impact factor: 1.636

2.  A casein kinase I motif present in the cytoplasmic domain of members of the tumour necrosis factor ligand family is implicated in 'reverse signalling'.

Authors:  A D Watts; N H Hunt; Y Wanigasekara; G Bloomfield; D Wallach; B D Roufogalis; G Chaudhri
Journal:  EMBO J       Date:  1999-04-15       Impact factor: 11.598

3.  Functional diversity of human protein kinase splice variants marks significant expansion of human kinome.

Authors:  Krishanpal Anamika; Nicolas Garnier; Narayanaswamy Srinivasan
Journal:  BMC Genomics       Date:  2009-12-22       Impact factor: 3.969

4.  Regulation of protein kinase CK1alphaLS by dephosphorylation in response to hydrogen peroxide.

Authors:  Shahinaz Bedri; Stephanie M Cizek; Iryna Rastarhuyeva; James R Stone
Journal:  Arch Biochem Biophys       Date:  2007-06-21       Impact factor: 4.013

5.  CKI isoforms α and ε regulate Star-PAP target messages by controlling Star-PAP poly(A) polymerase activity and phosphoinositide stimulation.

Authors:  Rakesh S Laishram; Christy A Barlow; Richard A Anderson
Journal:  Nucleic Acids Res       Date:  2011-07-04       Impact factor: 16.971

6.  Role for casein kinase 1 in the phosphorylation of Claspin on critical residues necessary for the activation of Chk1.

Authors:  Zheng Meng; Luisa Capalbo; David M Glover; William G Dunphy
Journal:  Mol Biol Cell       Date:  2011-06-16       Impact factor: 4.138

7.  Genome-wide review of transcriptional complexity in mouse protein kinases and phosphatases.

Authors:  Alistair R R Forrest; Darrin F Taylor; Mark L Crowe; Alistair M Chalk; Nic J Waddell; Gabriel Kolle; Geoffrey J Faulkner; Rimantas Kodzius; Shintaro Katayama; Christine Wells; Chikatoshi Kai; Jun Kawai; Piero Carninci; Yoshihide Hayashizaki; Sean M Grimmond
Journal:  Genome Biol       Date:  2006-01-26       Impact factor: 13.583

8.  The CK1α Activator Pyrvinium Enhances the Catalytic Efficiency (kcat/Km) of CK1α.

Authors:  Chen Shen; Bin Li; Luisana Astudillo; Murray P Deutscher; Melanie H Cobb; Anthony J Capobianco; Ethan Lee; David J Robbins
Journal:  Biochemistry       Date:  2019-12-10       Impact factor: 3.162

9.  Exploiting the MDM2-CK1α protein-protein interface to develop novel biologics that induce UBL-kinase-modification and inhibit cell growth.

Authors:  Anne-Sophie Huart; Nicola J MacLaine; Vikram Narayan; Ted R Hupp
Journal:  PLoS One       Date:  2012-08-20       Impact factor: 3.240

10.  CK1δ kinase activity is modulated by Chk1-mediated phosphorylation.

Authors:  Joachim Bischof; Sven-Jannis Randoll; Nadine Süßner; Doris Henne-Bruns; Lorenzo A Pinna; Uwe Knippschild
Journal:  PLoS One       Date:  2013-07-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.